The president and chief executive of Haemonetics Corp., which makes systems that process blood, exercised options for 50,000 shares of common stock, according to a Securities and Exchange Commission filing.
In a Form 4 filed Tuesday with the SEC, Brad Nutter reported he exercised the options Friday for $21.91 apiece and then sold all 50,000 shares on the same day for $55.05 apiece.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
Haemonetics is based in Braintree, Mass.